BioRestorative Therapies (BRTX) Debt/Equity Ratio: History & Chart

BioRestorative Therapies, Inc.(BRTX)

Biotechnology · Melville, NY

$2.27+0.03 (+1.34%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100. This treatment involves culturing mesenchymal stem cells harvested from a patient's own bone marrow (autologous) to provide a non-surgical solution for painful lumbosacral disc conditions. BRTX-100 has successfully completed Phase 1 clinical trials. The company is also advancing its Metabolic Program, named ThermoStem, which is currently in the preclinical stage. This cell-based therapy targets obesity and other metabolic ailments by employing brown adipose-derived stem cells to generate brown adipose tissue. Beyond these core programs, BioRestorative Therapies also offers an investigational curved needle device designed for delivering cells and various therapeutic materials to the spine and discs. The company fosters strategic research and development partnerships, including agreements with Rohto Pharmaceutical Co., Ltd., Pfizer, Inc., and the University of Pennsylvania. Founded in 1997 and headquartered in Melville, New York, the company was initially known as Stem Cell Assurance, Inc., before rebranding to BioRestorative Therapies, Inc. in August 2011.

Melville, NY

14 employees

www.biorestorative.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Katharyn Field

View full financials

BRTX Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.01

DEBT TO EQUITY RATIO AVG TTM

0.00

DEBT TO EQUITY RATIO AVG 3Y

0.01

DEBT TO EQUITY RATIO AVG 5Y

0.01

DEBT TO EQUITY RATIO AVG 10Y

-0.23

DEBT TO EQUITY RATIO AVG 15Y

-0.46

DEBT TO EQUITY RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+400.00%

CURRENT VS 3Y AVG

+44.83%

CURRENT VS 5Y AVG

-7.22%

CURRENT VS 10Y AVG

+105.07%

CURRENT VS 15Y AVG

+102.49%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.11

median of 773 covered companies

CURRENT VS SECTOR MEDIAN

-89.63%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
BioRestorative Therapies, Inc. (BRTX)	$3.14M	0.01	0.00	0.01	0.01
Adagio Medical Holdings, Inc. (ADGM)vs ›	$3.07M	N/A	1.28	1.28	0.64
Aethlon Medical, Inc. (AEMD)vs ›	$3.21M	0.07	0.10	0.11	0.08
MBody AI Ltd. (MBAI)vs ›	$3.25M	0.00	0.00	0.01	0.01
Paranovus Entertainment Technology Ltd. (PAVS)vs ›	$3.28M	0.02	0.06	0.17	0.12
Nexalin Technology, Inc. (NXL)vs ›	$3.30M	0.00	0.00	0.04	0.04
Revelation Biosciences, Inc. (REVB)vs ›	$2.94M	0.07	0.04	0.02	0.02
IceCure Medical Ltd (ICCM)vs ›	$2.86M	0.01	0.05	0.04	0.04
Mustang Bio, Inc. (MBIO)vs ›	$3.49M	0.00	0.00	7.00	4.21
Eocene Ltd. (EOCN)vs ›	$3.50M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

BioRestorative Therapies, Inc. (BRTX)

$3.14M

0.01

0.00

0.01

Adagio Medical Holdings, Inc. (ADGM)vs ›

$3.07M

N/A

1.28

0.64

Aethlon Medical, Inc. (AEMD)vs ›

$3.21M

0.07

0.10

0.11

0.08

MBody AI Ltd. (MBAI)vs ›

$3.25M

0.00

0.01

Paranovus Entertainment Technology Ltd. (PAVS)vs ›

$3.28M

0.02

0.06

0.17

0.12

Nexalin Technology, Inc. (NXL)vs ›

$3.30M

0.00

0.04

Revelation Biosciences, Inc. (REVB)vs ›

$2.94M

0.07

0.04

0.02

IceCure Medical Ltd (ICCM)vs ›

$2.86M

0.01

0.05

0.04

Mustang Bio, Inc. (MBIO)vs ›

$3.49M

0.00

7.00

4.21

Eocene Ltd. (EOCN)vs ›

$3.50M

N/A

Debt to Equity Ratio FAQ

What is the debt to equity ratio for BioRestorative Therapies, Inc. (BRTX)?

The debt to equity ratio for BRTX stock is 0.01.

Is BioRestorative Therapies, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.01 is in line with its 5-year average of 0.01, near the high end of its 5-year range (-1.94–0.03).

What is the TTM average debt to equity ratio for BioRestorative Therapies, Inc. (BRTX)?

The TTM average debt to equity ratio for BRTX stock is 0.00.

What is the 3Y average debt to equity ratio for BioRestorative Therapies, Inc. (BRTX)?

The 3Y average debt to equity ratio for BRTX stock is 0.01.

What is the 5Y average debt to equity ratio for BioRestorative Therapies, Inc. (BRTX)?

The 5Y average debt to equity ratio for BRTX stock is 0.01.

What is the 10Y average debt to equity ratio for BioRestorative Therapies, Inc. (BRTX)?

The 10Y average debt to equity ratio for BRTX stock is -0.23.

What is the 15Y average debt to equity ratio for BioRestorative Therapies, Inc. (BRTX)?

The 15Y average debt to equity ratio for BRTX stock is -0.46.

DATE	DEBT TO EQUITY RATIO
2026-03-31	0.01
2025-12-31	0.00
2025-09-30	0.00
2025-06-30	0.00
2025-03-31	0.00
2024-12-31	0.00
2024-09-30	0.00
2024-06-30	0.01
2024-03-31	0.01
2023-12-31	0.02
2023-09-30	0.02
2023-06-30	0.02
2023-03-31	0.02
2022-12-31	0.03
2022-09-30	0.02
2022-06-30	0.02
2022-03-31	0.02
2021-12-31	0.03
2021-09-30	-1.30
2021-06-30	-1.45
2021-03-31	-1.94
2020-12-31	-3.60
2020-09-30	-0.11
2020-06-30	-0.09
2020-03-31	-0.49
2019-12-31	-0.61
2019-09-30	-0.62
2019-06-30	-0.64
2019-03-31	-0.52
2018-12-31	-0.48
2018-09-30	-0.49
2018-06-30	-0.49
2018-03-31	-0.49
2017-12-31	-0.54
2017-09-30	-0.44
2017-06-30	-0.45
2017-03-31	-0.44
2016-12-31	-0.43
2016-09-30	-0.40
2016-06-30	-0.45
2016-03-31	-0.37
2015-12-31	-0.34
2015-09-30	-0.44
2015-06-30	-0.40
2015-03-31	-0.78
2014-12-31	-0.83
2014-09-30	-0.90
2014-06-30	-0.84
2014-03-31	-0.78
2013-12-31	-0.82
2013-09-30	-0.75
2013-06-30	-0.80
2013-03-31	-0.93
2012-12-31	-0.89
2012-09-30	-0.91
2012-06-30	-1.01
2012-03-31	-0.71
2011-12-31	-0.82
2011-09-30	-0.70
2011-06-30	-0.84
2011-03-31	0.00
2010-12-31	-0.96
2010-09-30	0.00

DATE

DEBT TO EQUITY RATIO

2026-03-31

0.01

2025-12-31

0.00

2025-09-30

0.00

2025-06-30

0.00

2025-03-31

0.00

2024-12-31

0.00

2024-09-30

0.00

2024-06-30

0.01

2024-03-31

0.01

2023-12-31

0.02

2023-09-30

0.02

2023-06-30

0.02

2023-03-31

0.02

2022-12-31

0.03

2022-09-30

0.02

2022-06-30

0.02

2022-03-31

0.02

2021-12-31

0.03

2021-09-30

-1.30

2021-06-30

-1.45

2021-03-31

-1.94

2020-12-31

-3.60

2020-09-30

-0.11

2020-06-30

-0.09

2020-03-31

-0.49

2019-12-31

-0.61

2019-09-30

-0.62

2019-06-30

-0.64

2019-03-31

-0.52

2018-12-31

-0.48

2018-09-30

-0.49

2018-06-30

-0.49

2018-03-31

-0.49

2017-12-31

-0.54

2017-09-30

-0.44

2017-06-30

-0.45

2017-03-31

-0.44

2016-12-31

-0.43

2016-09-30

-0.40

2016-06-30

-0.45

2016-03-31

-0.37

2015-12-31

-0.34

2015-09-30

-0.44

2015-06-30

-0.40

2015-03-31

-0.78

2014-12-31

-0.83

2014-09-30

-0.90

2014-06-30

-0.84

2014-03-31

-0.78

2013-12-31

-0.82

2013-09-30

-0.75

2013-06-30

-0.80

2013-03-31

-0.93

2012-12-31

-0.89

2012-09-30

-0.91

2012-06-30

-1.01

2012-03-31

-0.71

2011-12-31

-0.82

2011-09-30

-0.70

2011-06-30

-0.84

2011-03-31

0.00

2010-12-31

-0.96

2010-09-30

0.00

Debt to Equity Ratio: 0.01

BRTX Debt to Equity Ratio

BRTX Average Debt to Equity Ratio Chart

BRTX Current vs Average Debt to Equity Ratio Chart

BRTX Debt to Equity Ratio Metrics

BRTX Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

BRTX Debt to Equity Ratio History

Related Metrics